90 Participants Needed

Telehealth vs Web-Based CBT for Insomnia

(CLEAR Trial)

EN
CS
Overseen ByCatherine Siengsukon, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests different methods to help people with insomnia, particularly those with multiple sclerosis (MS). It compares one-on-one telehealth cognitive behavioral therapy (CBT) sessions, an online CBT program, and regular treatment (treatment as usual, TAU) to determine which best improves sleep, reduces fatigue, and enhances quality of life. Researchers will evaluate participants after 6 weeks and again 6 months later. This trial suits individuals with MS who struggle to fall or stay asleep at least three nights a week and have internet access. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, allowing participants to contribute to important findings.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you are taking benzodiazepines, non-benzodiazepines, or melatonin supplements for insomnia, you must have been on a stable dose for at least 3 months.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that telehealth cognitive behavioral therapy for insomnia (tCBT-I) is safe. One study found that 85% of interested participants qualified, and 98% completed the program, suggesting most can undergo treatment without major issues.

Similarly, web-based CBT-I (wCBT-I) is a safe and effective method for improving sleep. A review of several studies confirmed that internet-based CBT-I significantly improved sleep issues without notable side effects. Another study found it effective even for individuals with other health conditions, such as cancer survivors, again without major safety concerns.

Both treatments are types of behavioral therapy, focusing on changing habits and thoughts rather than using medication. This often results in fewer side effects compared to drug treatments. Overall, research supports that both telehealth and web-based CBT-I are safe options for improving sleep.12345

Why are researchers excited about this trial?

Researchers are excited about the trial comparing telehealth and web-based cognitive behavioral therapy for insomnia because these approaches offer unique flexibility and accessibility that standard treatments, like in-person therapy or medication, often lack. Telehealth CBT-I provides personalized, one-on-one sessions through video conferencing, making it easier for individuals with busy schedules or mobility issues to receive care from home. Meanwhile, the web-based CBT-I program delivers structured, interactive lessons that patients can work through at their own pace, accommodating different learning styles and schedules. These innovative delivery methods could make effective insomnia treatment more widely available and convenient for people who struggle to access traditional in-person therapy.

What evidence suggests that this trial's treatments could be effective for insomnia?

This trial will compare Telehealth cognitive behavioral therapy for insomnia (tCBT-I) with Web-based cognitive behavioral therapy for insomnia (wCBT-I) and Treatment as usual (TAU). Research has shown that telehealth cognitive behavioral therapy for insomnia (tCBT-I) can greatly improve sleep quality and reduce insomnia symptoms. One study found that it improved insomnia severity, sleep efficiency, and overall sleep quality. Another study showed that telehealth and in-person CBT-I were equally effective for treating insomnia. Web-based CBT-I (wCBT-I) is also effective, with research confirming it improves sleep both in subjective and measurable ways. Online programs can lessen insomnia severity and reduce pre-sleep alertness. Both telehealth and web-based CBT-I have shown promising results in enhancing sleep quality.24678

Are You a Good Fit for This Trial?

This trial is for adults aged 18-65 with relapsing-remitting or secondary progressive MS, experiencing sleep issues at least three nights a week for the past three months. Participants should have mild-to-moderate disability, be English-speaking, and have internet access. Those with severe disabilities or other sleep disorders are excluded.

Inclusion Criteria

My disability level is mild to moderate.
I speak English.
My neurologist confirmed I have relapsing-remitting or secondary progressive MS.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either telehealth-delivered CBT-I or web-based CBT-I for 6 weeks

6 weeks
1 visit per week (telehealth or web-based)

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months
Reassessment at 6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Telehealth cognitive behavioral therapy for insomnia (tCBT-I)
  • Treatment as usual (TAU)
  • Web-based cognitive behavioral therapy for insomnia (wCBT-I)
Trial Overview The study compares one-on-one telehealth CBT-I (tCBT-I) and web-based CBT-I (wCBT-I) against usual treatments to see which improves sleep, reduces fatigue, enhances quality of life, and potentially protects the brain in people with MS.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Web-based cognitive behavioral therapy for insomnia (wCBT-I)Experimental Treatment1 Intervention
Group II: Treatment as usual (TAU)Experimental Treatment1 Intervention
Group III: Telehealth cognitive behavioral therapy for insomnia (tCBT-I)Experimental Treatment1 Intervention

Telehealth cognitive behavioral therapy for insomnia (tCBT-I) is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Cognitive Behavioral Therapy for Insomnia for:
🇪🇺
Approved in European Union as Cognitive Behavioral Therapy for Insomnia for:
🇨🇦
Approved in Canada as Cognitive Behavioral Therapy for Insomnia for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Kansas Medical Center

Lead Sponsor

Trials
527
Recruited
181,000+

Published Research Related to This Trial

The Tele-Insomnia program successfully delivered group cognitive behavioral treatment for insomnia (CBT-I) via telehealth to veterans, resulting in significant improvements in insomnia severity and sleep quality, as measured by the Insomnia Severity Index and sleep diaries.
The program demonstrated excellent video quality and minimal connectivity issues, indicating that telehealth is a viable and scalable option for providing effective insomnia treatment to increase access for patients.
Feasibility of Group Cognitive-Behavioral Treatment of Insomnia Delivered by Clinical Video Telehealth.Gehrman, P., Shah, MT., Miles, A., et al.[2018]
Both internet-based cognitive behavioral treatments for insomnia (MCT and SRT) were significantly more effective than care as usual, with MCT showing a large effect size for insomnia severity (Cohen's d = -1.15) after eight weeks.
Participants in the multi-component treatment (MCT) reported higher satisfaction compared to those in the sleep restriction treatment (SRT), although both treatments had similar efficacy outcomes.
A randomized controlled trial comparing guided internet-based multi-component treatment and internet-based guided sleep restriction treatment to care as usual in insomnia.Krieger, T., Urech, A., Duss, SB., et al.[2020]
Computerized cognitive behavioral therapy for insomnia (CCBT-I) has been shown to significantly improve various sleep-related outcomes, such as sleep quality and sleep efficiency, based on a meta-analysis of 6 randomized controlled trials involving 533 papers.
With a high treatment adherence rate of 78% and a moderate effect size, CCBT-I is considered a viable low-intensity self-help therapy for insomnia, making it a useful option in stepped care models for treating sleep disorders.
Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis.Cheng, SK., Dizon, J.[2022]

Citations

Telehealth-Delivered Cognitive Behavioral Therapy for ...One recent study reported a significant improvement in insomnia symptoms, sleep quality, fatigue, sleep self-efficacy, and depression symptoms ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39186370/
Efficacy of eHealth Versus In-Person Cognitive Behavioral ...Conclusions: eCBTI and ipCBTI were found to be statistically significantly equivalent for treating insomnia for most examined outcomes, ...
Digital Cognitive Behavioral Therapy vs Medication ...In this study, clinical evidence suggested that combination therapy was optimal, and dCBT-I was more effective than medication therapy, with long-term benefits ...
Internet-delivered Cognitive Behavioral Therapy for Insomniaconfirmed that eCBT-I significantly improves insomnia severity, sleep efficiency, sleep quality, latency, and total sleep time, achieving ...
Comparative efficacy of onsite, digital, and other settings ...All examined CBT-I settings except telehealth yielded a significant reduction of the objective total sleep time compared to WL. Medium negative ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/37796017/
Telehealth group Cognitive-Behavioral Therapy for Insomnia ...Results: Telehealth group CBT-I was deemed safe. Following the 76% screening rate, 85% of interested individuals met study eligibility and 98% ...
Digital cognitive behavioral therapy for insomniaThe AASM recommends clinicians use cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment for chronic insomnia in adults.
A randomized controlled trial of a digital cognitive ...Meta-analyses support CBT-I as efficacious and safe, with long-lasting effects in older adults. As a behavioral rather than pharmacological ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security